{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T12:17:16Z","timestamp":1783772236139,"version":"3.55.0"},"publisher-location":"Cham","reference-count":131,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032121653","type":"print"},{"value":"9783032121660","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-032-12166-0_5","type":"book-chapter","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T11:16:36Z","timestamp":1783768596000},"page":"145-164","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic Reprogramming in the Bladder Cancer Microenvironment: Bridging Fundamental Research and Therapeutic Avenues for Cancer-Associated Fibroblasts"],"prefix":"10.1007","author":[{"given":"Ana","family":"Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1tima","family":"Baltazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julieta","family":"Afonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,12]]},"reference":[{"issue":"1","key":"5_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41420-024-01910-x","volume":"10","author":"A Affinito","year":"2024","unstructured":"Affinito A, Quintavalle C, Chianese RV, Roscigno G, Fiore D, D\u2019Argenio V, Thomas G, Savarese A, Ingenito F, Cocca L, Nuzzo S, Berezovski MV, Stoppelli MP, Condorelli G (2024) MCT4-driven CAF-mediated metabolic reprogramming in breast cancer microenvironment is a vulnerability targetable by miR-425-5p. Cell Death Discov 10(1):1\u201313","journal-title":"Cell Death Discov"},{"issue":"7","key":"5_CR2","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.3390\/cancers16071418","volume":"16","author":"J Afonso","year":"2024","unstructured":"Afonso J, Barbosa-Matos C, Silvestre R, Pereira-Vieira J, Gon\u00e7alves SM, Mendes-Alves C, Parpot P, Pinto J, Carapito \u00c2, Guedes de Pinho P, Santos L, Longatto-Filho A, Baltazar F (2024) Cisplatin-resistant urothelial bladder cancer cells undergo metabolic reprogramming beyond the Warburg effect. Cancers 16(7):1418","journal-title":"Cancers"},{"issue":"3","key":"5_CR3","doi-asserted-by":"publisher","first-page":"982","DOI":"10.3390\/cancers15030982","volume":"15","author":"J Afonso","year":"2023","unstructured":"Afonso J, Gon\u00e7alves C, Costa M, Ferreira D, Santos L, Longatto-Filho A, Baltazar F (2023) Glucose metabolism reprogramming in bladder cancer: hexokinase 2 (HK2) as prognostic biomarker and target for bladder cancer therapy. Cancers 15(3):982","journal-title":"Cancers"},{"issue":"3","key":"5_CR4","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1080\/15384101.2015.1121329","volume":"15","author":"J Afonso","year":"2016","unstructured":"Afonso J, Santos LL, Morais A, Amaro T, Longatto-Filho A, Baltazar F (2016) Metabolic coupling in urothelial bladder cancer compartments and its correlation to tumor aggressiveness. Cell Cycle 15(3):368\u2013380","journal-title":"Cell Cycle"},{"issue":"11","key":"5_CR5","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/nm.3389","volume":"19","author":"D Amakye","year":"2013","unstructured":"Amakye D, Jagani Z, Dorsch M (2013) Unraveling the therapeutic potential of the Hedgehog pathway in cancer. Nature Med 19(11):1410\u20131422","journal-title":"Nature Med"},{"issue":"16","key":"5_CR6","doi-asserted-by":"publisher","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","volume":"30","author":"NM Anderson","year":"2020","unstructured":"Anderson NM, Simon MC (2020) The tumor microenvironment. Curr Biol 30(16):R921\u2013R925","journal-title":"Curr Biol"},{"issue":"12","key":"5_CR7","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.it.2022.10.005","volume":"43","author":"P Apostolova","year":"2022","unstructured":"Apostolova P, Pearce EL (2022) Lactic acid and lactate: revisiting the physiological roles in the tumor microenvironment. Trends Immunol 43(12):969\u2013977","journal-title":"Trends Immunol"},{"issue":"1","key":"5_CR8","first-page":"15","volume":"56","author":"B Arneth","year":"2019","unstructured":"Arneth B (2019) Tumor microenvironment. Medicina 2020 56(1):15","journal-title":"Medicina 2020"},{"issue":"1","key":"5_CR9","first-page":"6075403","volume":"2018","author":"A Avagliano","year":"2018","unstructured":"Avagliano A, Granato G, Ruocco MR, Romano V, Belviso I, Carfora A, Montagnani S, Arcucci A (2018) Metabolic reprogramming of cancer associated fibroblasts: the slavery of stromal fibroblasts. BioMed Res Int 2018(1):6075403","journal-title":"BioMed Res Int"},{"key":"5_CR10","doi-asserted-by":"publisher","first-page":"520394","DOI":"10.3389\/fonc.2020.00231","volume":"10","author":"F Baltazar","year":"2020","unstructured":"Baltazar F, Afonso J, Costa M, Granja S (2020) Lactate beyond a waste metabolite: metabolic affairs and signaling in malignancy. Front Oncol 10:520394","journal-title":"Front Oncol"},{"key":"5_CR11","doi-asserted-by":"publisher","first-page":"110216","DOI":"10.1016\/j.mehy.2020.110216","volume":"144","author":"S Benny","year":"2020","unstructured":"Benny S, Mishra R, Manojkumar MK, Aneesh TP (2020) From Warburg effect to reverse Warburg effect: the new horizons of anti-cancer therapy. Med Hypotheses 144:110216","journal-title":"Med Hypotheses"},{"issue":"7","key":"5_CR12","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.molonc.2014.04.006","volume":"8","author":"M Berdiel-Acer","year":"2014","unstructured":"Berdiel-Acer M, Sanz-Pamplona R, Calon A, Cuadras D, Berenguer A, Sanjuan X, Paules MJ, Salazar R, Moreno V, Batlle E, Villanueva A, Mollev\u00ed DG (2014) Differences between CAFs and their paired NCF from adjacent colonic mucosa reveal functional heterogeneity of CAFs, providing prognostic information. Mol Oncol 8(7):1290\u20131305","journal-title":"Mol Oncol"},{"issue":"5659","key":"5_CR13","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1126\/science.1090922","volume":"303","author":"NA Bhowmick","year":"2004","unstructured":"Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, Washington MK, Neilson EG, Moses HL (2004) TGF-\u03b2 signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303(5659):848\u2013851","journal-title":"Science"},{"issue":"1","key":"5_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00048.2019","volume":"101","author":"G Biffi","year":"2021","unstructured":"Biffi G, Tuveson DA (2021) Diversity and biology of cancer associated fibroblasts. Physiol Rev 101(1):147\u2013176","journal-title":"Physiol Rev"},{"issue":"3","key":"5_CR15","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"5_CR16","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.1111\/cas.14578","volume":"111","author":"L Bu","year":"2020","unstructured":"Bu L, Baba H, Yasuda T, Uchihara T, Ishimoto T (2020) Functional diversity of cancer-associated fibroblasts in modulating drug resistance. Cancer Sci 111(10):3468\u20133477","journal-title":"Cancer Sci"},{"issue":"3","key":"5_CR17","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.ccell.2023.02.015","volume":"41","author":"G Caligiuri","year":"2023","unstructured":"Caligiuri G, Tuveson DA (2023) Activated fibroblasts in cancer: perspectives and challenges. Cancer Cell 41(3):434\u2013449","journal-title":"Cancer Cell"},{"issue":"12","key":"5_CR18","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.3390\/cancers13122972","volume":"13","author":"S Camargo","year":"2021","unstructured":"Camargo S, Gofrit ON, Assis A, Mitrani E (2021) Paracrine signaling from a three-dimensional model of bladder carcinoma and from normal bladder switch the phenotype of stromal fibroblasts. Cancers 13(12):2972","journal-title":"Cancers"},{"key":"5_CR19","doi-asserted-by":"crossref","unstructured":"Ca\u00f1izo CG, Guerrero-Ramos F, Perez Escavy M, Lodewijk I, Su\u00e1rez-Cabrera C, Morales L et al (2025) Characterisation of the tumour microenvironment and PD-L1 granularity reveals the prognostic value of cancer-associated myofibroblasts in non-invasive bladder cancer. OncoImmunology 14(1):2438291","DOI":"10.1080\/2162402X.2024.2438291"},{"issue":"4","key":"5_CR20","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.euo.2023.02.011","volume":"6","author":"B Caramelo","year":"2023","unstructured":"Caramelo B, Zagorac S, Corral S, Marqu\u00e9s M, Real FX (2023) Cancer-associated fibroblasts in bladder cancer: origin, biology, and therapeutic opportunities. Eur Urol Oncol 6(4):366\u2013375","journal-title":"Eur Urol Oncol"},{"issue":"2","key":"5_CR21","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/jcmm.16132","volume":"25","author":"RA Caston","year":"2021","unstructured":"Caston RA, Shah F, Starcher CL, Wireman R, Babb O, Grimard M, McGeown J, Armstrong L, Tong Y, Pili R, Rupert J, Zimmers TA, Elmi AN, Pollok KE, Motea EA, Kelley MR, Fishel ML (2021) Combined inhibition of Ref-1 and STAT3 leads to synergistic tumour inhibition in multiple cancers using 3D and in vivo tumour co-culture models. J Cell Mol Med 25(2):784\u2013800","journal-title":"J Cell Mol Med"},{"issue":"9","key":"5_CR22","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1054\/bjoc.2001.2105","volume":"85","author":"N Cattan","year":"2001","unstructured":"Cattan N, Rochet N, Mazeau C, Zanghellini E, Mari B, Chauzy C, De Novion HS, Amiel J, Lagrange JL, Rossi B, Gioanni J (2001) Establishment of two new human bladder carcinoma cell lines, CAL 29 and CAL 185. Comparative study of cell scattering and epithelial to mesenchyme transition induced by growth factors. Br J Cancer 85(9):1412\u20131417","journal-title":"Br J Cancer"},{"issue":"24","key":"5_CR23","doi-asserted-by":"publisher","first-page":"15970","DOI":"10.3390\/ijms232415970","volume":"23","author":"H Chen","year":"2022","unstructured":"Chen H, Yang W, Xue X, Li Y, Jin Z, Ji Z (2022) Integrated analysis revealed an inflammatory cancer-associated fibroblast-based subtypes with promising implications in predicting the prognosis and immunotherapeutic response of bladder cancer patients. Int J Mol Sci 23(24):15970","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5_CR24","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s12094-023-03270-x","volume":"26","author":"X Chen","year":"2024","unstructured":"Chen X, Liao C, Zou X, Zhang B, Mo Z (2024) A gene signature of cancer-associated fibroblasts predicts prognosis and treatment response in bladder cancer. Clin Transl Oncol 26(2):477\u2013495","journal-title":"Clin Transl Oncol"},{"issue":"2","key":"5_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","volume":"18","author":"X Chen","year":"2018","unstructured":"Chen X, Song E (2018) Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discovery 18(2):99\u2013115","journal-title":"Nat Rev Drug Discovery"},{"issue":"1","key":"5_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-18916-5","volume":"11","author":"Z Chen","year":"2020","unstructured":"Chen Z, Zhou L, Liu L, Hou Y, Xiong M, Yang Y, Hu J, Chen K (2020) Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma. Nat Commun 11(1):1\u201312","journal-title":"Nat Commun"},{"issue":"1","key":"5_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1741-7015-11-13","volume":"11","author":"G Cheung","year":"2013","unstructured":"Cheung G, Sahai A, Billia M, Dasgupta P, Khan MS (2013) Recent advances in the diagnosis and treatment of bladder cancer. BMC Med 11(1):1\u20138","journal-title":"BMC Med"},{"issue":"3","key":"5_CR28","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ccell.2018.01.011","volume":"33","author":"A Costa","year":"2018","unstructured":"Costa A, Kieffer Y, Scholer-Dahirel A, Pelon F, Bourachot B, Cardon M, Sirven P, Magagna I, Fuhrmann L, Bernard C, Bonneau C, Kondratova M, Kuperstein I, Zinovyev A, Givel AM, Parrini MC, Soumelis V, Vincent-Salomon A, Mechta-Grigoriou F (2018) Fibroblast heterogeneity and immunosuppressive environment in human breast cancer. Cancer Cell 33(3):463\u2013479. e10","journal-title":"Cancer Cell"},{"key":"5_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.semcancer.2013.12.007","volume":"25","author":"A Costa","year":"2014","unstructured":"Costa A, Scholer-Dahirel A, Mechta-Grigoriou F (2014) The role of reactive oxygen species and metabolism on cancer cells and their microenvironment. Sem Cancer Biol 25:23\u201332","journal-title":"Sem Cancer Biol"},{"issue":"8","key":"5_CR30","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/dvg.20769","volume":"49","author":"AS Cuttler","year":"2011","unstructured":"Cuttler AS, Leclair RJ, Stohn JP, Wang Q, Sorenson CM, Liaw L, Lindner V (2011) Characterization of Pdgfrb-Cre transgenic mice reveals reduction of ROSA26 reporter activity in remodeling arteries. Genesis 49(8):673\u2013680","journal-title":"Genesis"},{"issue":"5","key":"5_CR31","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1634\/stemcells.21-5-514","volume":"21","author":"NC Direkze","year":"2003","unstructured":"Direkze NC, Forbes SJ, Brittan M, Hunt T, Jeffery R, Preston SL, Poulsom R, Hodivala-Dilke K, Alison MR, Wright NA (2003) Multiple organ engraftment by bone-marrow-derived myofibroblasts and fibroblasts in bone-marrow-transplanted mice. Stem Cells 21(5):514\u2013520","journal-title":"Stem Cells"},{"issue":"1","key":"5_CR32","first-page":"6645220","volume":"2021","author":"D Dong","year":"2021","unstructured":"Dong D, Yao Y, Song J, Sun L, Zhang G (2021) Cancer-associated fibroblasts regulate bladder cancer invasion and metabolic phenotypes through autophagy. Dis Markers 2021(1):6645220","journal-title":"Dis Markers"},{"issue":"1","key":"5_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-021-02314-y","volume":"21","author":"YH Du","year":"2021","unstructured":"Du YH, Cao J, Jiang X, Cai XW, Wang B, Wang Y, Wang XZ, Xue BX (2021a) Comprehensive analysis of CXCL12 expression reveals the significance of inflammatory fibroblasts in bladder cancer carcinogenesis and progression. Cancer Cell Int 21(1):1\u201315","journal-title":"Cancer Cell Int"},{"issue":"1","key":"5_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-021-01896-x","volume":"21","author":"YH Du","year":"2021","unstructured":"Du YH, Jiang X, Wang B, Cao J, Wang Y, Yu J, Wang XZ, Liu HT (2021b) The cancer-associated fibroblasts related gene CALD1 is a prognostic biomarker and correlated with immune infiltration in bladder cancer. Cancer Cell Int 21(1):1\u201315","journal-title":"Cancer Cell Int"},{"key":"5_CR35","doi-asserted-by":"publisher","first-page":"833578","DOI":"10.3389\/fcell.2022.833578","volume":"10","author":"YH Du","year":"2022","unstructured":"Du YH, Sui YQ, Cao J, Jiang X, Wang Y, Yu J, Wang B, Wang XZ, Xue BX (2022) Dynamic changes in myofibroblasts affect the carcinogenesis and prognosis of bladder cancer associated with tumor microenvironment remodeling. Front Cell Dev Biol 10:833578","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"5_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-022-03368-y","volume":"5","author":"J Eng","year":"2022","unstructured":"Eng J, Bucher E, Hu Z, Zheng T, Gibbs SL, Chin K, Gray JW (2022) A framework for multiplex imaging optimization and reproducible analysis. Commun Biol 5(1):1\u201311","journal-title":"Commun Biol"},{"issue":"2","key":"5_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ccr.2009.12.041","volume":"17","author":"N Erez","year":"2010","unstructured":"Erez N, Truitt M, Olson P, Hanahan D (2010) Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-\u03baB-dependent manner. Cancer Cell 17(2):135\u2013147","journal-title":"Cancer Cell"},{"issue":"1","key":"5_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.semcdb.2009.10.010","volume":"21","author":"OE Franco","year":"2010","unstructured":"Franco OE, Shaw AK, Strand DW, Hayward SW (2010) Cancer associated fibroblasts in cancer pathogenesis. Semin Cell Dev Biol 21(1):33\u201339","journal-title":"Semin Cell Dev Biol"},{"issue":"34","key":"5_CR39","doi-asserted-by":"publisher","first-page":"57813","DOI":"10.18632\/oncotarget.18175","volume":"8","author":"Y Fu","year":"2017","unstructured":"Fu Y, Liu S, Yin S, Niu W, Xiong W, Tan M, Li G, Zhou M (2017) The reverse Warburg effect is likely to be an Achilles\u2019 heel of cancer that can be exploited for cancer therapy. Oncotarget 8(34):57813","journal-title":"Oncotarget"},{"issue":"4","key":"5_CR40","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41416-019-0509-3","volume":"121","author":"KA Gieniec","year":"2019","unstructured":"Gieniec KA, Butler LM, Worthley DL, Woods SL (2019) Cancer-associated fibroblasts\u2014heroes or villains? Br J Cancer 121(4):293\u2013302","journal-title":"Br J Cancer"},{"issue":"1","key":"5_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-019-5353-6","volume":"19","author":"CR Goulet","year":"2019","unstructured":"Goulet CR, Champagne A, Bernard G, Vandal D, Chabaud S, Pouliot F, Bolduc S (2019) Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling. BMC Cancer 19(1):1\u201313","journal-title":"BMC Cancer"},{"issue":"1","key":"5_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yexcr.2015.04.001","volume":"335","author":"S Grimm","year":"2015","unstructured":"Grimm S, Jennek S, Singh R, Enkelmann A, Junker K, Rippaus N, Berndt A, Friedrich K (2015) Malignancy of bladder cancer cells is enhanced by tumor-associated fibroblasts through a multifaceted cytokine-chemokine loop. Exp Cell Res 335(1):1\u201311","journal-title":"Exp Cell Res"},{"issue":"1","key":"5_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12894-023-01239-0","volume":"23","author":"S Gu","year":"2023","unstructured":"Gu S, Yang C (2023) Serum lactate dehydrogenase level predicts the prognosis in bladder cancer patients. BMC Urol 23(1):1\u20138","journal-title":"BMC Urol"},{"issue":"6","key":"5_CR44","doi-asserted-by":"publisher","first-page":"e99955","DOI":"10.1371\/journal.pone.0099955","volume":"9","author":"SY Ha","year":"2014","unstructured":"Ha SY, Yeo SY, Xuan YH, Kim SH (2014) The prognostic significance of cancer-associated fibroblasts in esophageal squamous cell carcinoma. PLoS One 9(6):e99955","journal-title":"PLoS One"},{"issue":"2","key":"5_CR45","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/iub.572","volume":"64","author":"AP Halestrap","year":"2012","unstructured":"Halestrap AP, Wilson MC (2012) The monocarboxylate transporter family\u2014role and regulation. IUBMB Life 64(2):109\u2013119","journal-title":"IUBMB Life"},{"issue":"8","key":"5_CR46","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1158\/1078-0432.CCR-22-2263","volume":"29","author":"S Halford","year":"2023","unstructured":"Halford S, Veal GJ, Wedge SR, Payne GS, Bacon CM, Sloan P, Dragoni I, Heinzmann K, Potter S, Salisbury BM, Chenard-Poirier M, Greystoke A, Howell EC, Innes WA, Morris K, Plummer C, Rata M, Petrides G, Keun HC et al (2023) A phase I dose-escalation study of AZD3965, an oral monocarboxylate transporter 1 inhibitor, in patients with advanced cancer. Clin Cancer Res 29(8):1429\u20131439","journal-title":"Clin Cancer Res"},{"issue":"1","key":"5_CR47","first-page":"e1647","volume":"6","author":"T Hamabe-Horiike","year":"2023","unstructured":"Hamabe-Horiike T, Harada SI, Yoshida K, Kinoshita J, Yamaguchi T, Fushida S (2023) Adipocytes contribute to tumor progression and invasion of peritoneal metastasis by interacting with gastric cancer cells as cancer associated fibroblasts. Cancer Rep 6(1):e1647","journal-title":"Cancer Rep"},{"issue":"1","key":"5_CR48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D (2022) Hallmarks of cancer: new dimensions. Cancer Discov 12(1):31\u201346","journal-title":"Cancer Discov"},{"issue":"1","key":"5_CR49","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000147748","volume":"154","author":"ED Hay","year":"1995","unstructured":"Hay ED, Words K (1995) An overview of epithelio-mesenchymal transformation. Acta Anat 154(1):8\u201320","journal-title":"Acta Anat"},{"issue":"17","key":"5_CR50","doi-asserted-by":"publisher","first-page":"6072","DOI":"10.3390\/ijms21176072","volume":"21","author":"T Hayashi","year":"2020","unstructured":"Hayashi T, Fujita K, Hayashi Y, Hatano K, Kawashima A, McConkey DJ, Nonomura N (2020) Mutational landscape and environmental effects in bladder cancer. Int J Mol Sci 21(17):6072","journal-title":"Int J Mol Sci"},{"key":"5_CR51","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.canlet.2020.12.021","volume":"500","author":"C Hayes","year":"2021","unstructured":"Hayes C, Donohoe CL, Davern M, Donlon NE (2021) The oncogenic and clinical implications of lactate induced immunosuppression in the tumour microenvironment. Cancer Lett 500:75\u201386","journal-title":"Cancer Lett"},{"issue":"5930","key":"5_CR52","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MGV Heiden","year":"2009","unstructured":"Heiden MGV, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324(5930):1029\u20131033","journal-title":"Science"},{"issue":"38","key":"5_CR53","doi-asserted-by":"publisher","first-page":"E5618","DOI":"10.1073\/pnas.1608384113","volume":"113","author":"K Hosaka","year":"2016","unstructured":"Hosaka K, Yang Y, Seki T, Fischer C, Dubey O, Fredlund E, Hartman J, Religa P, Morikawa H, Ishii Y, Sasahara M, Larsson O, Cossu G, Cao R, Lim S, Cao Y (2016) Pericyte-fibroblast transition promotes tumor growth and metastasis. Proc Natl Acad Sci USA 113(38):E5618\u2013E5627","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"5_CR54","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.cell.2008.08.021","volume":"134","author":"PP Hsu","year":"2008","unstructured":"Hsu PP, Sabatini DM (2008) Cancer cell metabolism: Warburg and beyond. Cell 134(5):703\u2013707","journal-title":"Cell"},{"key":"5_CR55","doi-asserted-by":"crossref","unstructured":"Huang B, Huang M, Li Q (2019) Cancer-associated fibroblasts promote angiogenesis of hepatocellular carcinoma by VEGF-mediated EZH2\/VASH1 pathway. Technol Cancer Res Treat 18:1533033819879905","DOI":"10.1177\/1533033819879905"},{"issue":"9","key":"5_CR56","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1016\/j.heliyon.2023.e19802","volume":"9","author":"L Huang","year":"2023","unstructured":"Huang L, Xie Q, Deng J, Wei WF (2023) The role of cancer-associated fibroblasts in bladder cancer progression. Heliyon 9(9):2405\u20138440","journal-title":"Heliyon"},{"issue":"3","key":"5_CR57","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1172\/JCI15518","volume":"110","author":"M Iwano","year":"2002","unstructured":"Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG (2002) Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110(3):341\u2013350. https:\/\/doi.org\/10.1172\/JCI15518","journal-title":"J Clin Invest"},{"issue":"2","key":"5_CR58","doi-asserted-by":"publisher","first-page":"403","DOI":"10.4081\/oncol.2019.403","volume":"13","author":"A Javaeed","year":"2019","unstructured":"Javaeed A, Ghauri SK (2019) MCT4 has a potential to be used as a prognostic biomarker\u2014a systematic review and meta-analysis. Oncol Rev 13(2):403","journal-title":"Oncol Rev"},{"issue":"1","key":"5_CR59","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/cells9010217","volume":"9","author":"W Jin","year":"2020","unstructured":"Jin W (2020) Role of JAK\/STAT3 signaling in the regulation of metastasis, the transition of cancer stem cells, and chemoresistance of cancer by epithelial\u2013mesenchymal transition. Cells 9(1):217","journal-title":"Cells"},{"issue":"6","key":"5_CR60","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3390\/cancers13061399","volume":"13","author":"RS Joshi","year":"2021","unstructured":"Joshi RS, Kanugula SS, Sudhir S, Pereira MP, Jain S, Aghi MK (2021) The role of cancer-associated fibroblasts in tumor progression. Cancers 13(6):1399","journal-title":"Cancers"},{"issue":"6230","key":"5_CR61","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","volume":"348","author":"JA Joyce","year":"2015","unstructured":"Joyce JA, Fearon DT (2015) T cell exclusion, immune privilege, and the tumor microenvironment. Science 348(6230):74\u201380","journal-title":"Science"},{"issue":"9","key":"5_CR62","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1002\/cyto.a.23101","volume":"93","author":"Z Kahounov\u00e1","year":"2018","unstructured":"Kahounov\u00e1 Z, Kurf\u00fcrstov\u00e1 D, Bouchal J, Kharaishvili G, Navr\u00e1til J, Rem\u0161\u00edk J, \u0160ime\u010dkov\u00e1 \u0160, \u0160tudent V, Kozub\u00edk A, Sou\u010dek K (2018) The fibroblast surface markers FAP, anti-fibroblast, and FSP are expressed by cells of epithelial origin and may be altered during epithelial-to-mesenchymal transition. Cytometry, Part A 93(9):941\u2013951","journal-title":"Cytometry, Part A"},{"issue":"10061","key":"5_CR63","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","volume":"388","author":"AM Kamat","year":"2016","unstructured":"Kamat AM, Hahn NM, Efstathiou JA, Lerner SP, Malmstr\u00f6m PU, Choi W, Guo CC, Lotan Y, Kassouf W (2016) Bladder cancer. Lancet 388(10061):2796\u20132810","journal-title":"Lancet"},{"issue":"Suppl 4","key":"5_CR64","doi-asserted-by":"publisher","first-page":"S744","DOI":"10.21037\/tcr.2017.06.48","volume":"6","author":"HW Kang","year":"2017","unstructured":"Kang HW, Kim WJ, Yun SJ (2017) The role of the tumor microenvironment in bladder cancer development and progression. Trans Cancer Res 6(Suppl 4):S744\u2013S758","journal-title":"Trans Cancer Res"},{"issue":"6005","key":"5_CR65","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1126\/science.1195300","volume":"330","author":"M Kraman","year":"2010","unstructured":"Kraman M, Bambrough PJ, Arnold JN, Roberts EW, Magiera L, Jones JO, Gopinathan A, Tuveson DA, Fearon DT (2010) Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-\u03b1. Science 330(6005):827\u2013830","journal-title":"Science"},{"issue":"1","key":"5_CR66","first-page":"1","volume":"10","author":"YC Lee","year":"2019","unstructured":"Lee YC, Kurtova AV, Xiao J, Nikolos F, Hayashi K, Tramel Z, Jain A, Chen F, Chokshi M, Lee C, Bao G, Zhang X, Shen J, Mo Q, Jung SY, Rowley D, Chan KS (2019) Collagen-rich airway smooth muscle cells are a metastatic niche for tumor colonization in the lung. Nat Commun 10(1):1\u201316","journal-title":"Nat Commun"},{"key":"5_CR67","doi-asserted-by":"publisher","first-page":"145451","DOI":"10.1016\/j.gene.2021.145451","volume":"775","author":"B Liu","year":"2021","unstructured":"Liu B, Pan S, Liu J, Kong C (2021) Cancer-associated fibroblasts and the related Runt-related transcription factor 2 (RUNX2) promote bladder cancer progression. Gene 775:145451","journal-title":"Gene"},{"issue":"14","key":"5_CR68","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1158\/0008-5472.CAN-14-3041","volume":"75","author":"A Lo","year":"2015","unstructured":"Lo A, Wang LCS, Scholler J, Monslow J, Avery D, Newick K, O\u2019Brien S, Evans RA, Bajor DJ, Clendenin C, Durham AC, Buza EL, Vonderheide RH, June CH, Albelda SM, Pure E (2015) Tumor-promoting desmoplasia is disrupted by depleting FAP-expressing stromal cells. Cancer Res 75(14):2800\u20132810","journal-title":"Cancer Res"},{"issue":"6","key":"5_CR69","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","volume":"5","author":"N Lobo","year":"2022","unstructured":"Lobo N, Afferi L, Moschini M, Mostafid H, Porten S, Psutka SP, Gupta S, Smith AB, Williams SB, Lotan Y (2022) Epidemiology, screening, and prevention of bladder cancer. Eur Urol Oncol 5(6):628\u2013639","journal-title":"Eur Urol Oncol"},{"issue":"7","key":"5_CR70","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1172\/JCI26532","volume":"116","author":"M Loeffler","year":"2006","unstructured":"Loeffler M, Kr\u00fcger JA, Niethammer AG, Reisfeld RA (2006) Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. J Clin Invest 116(7):1955\u20131962","journal-title":"J Clin Invest"},{"issue":"5","key":"5_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-019-1581-6","volume":"10","author":"X Long","year":"2019","unstructured":"Long X, Xiong W, Zeng X, Qi L, Cai Y, Mo M, Jiang H, Zhu B, Chen Z, Li Y (2019) Cancer-associated fibroblasts promote cisplatin resistance in bladder cancer cells by increasing IGF-1\/ER\u03b2\/Bcl-2 signalling. Cell Death Dis 10(5):1\u201316","journal-title":"Cell Death Dis"},{"issue":"11","key":"5_CR72","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.3390\/cancers12113108","volume":"12","author":"K Louault","year":"2020","unstructured":"Louault K, Li RR, Declerck YA (2020) Cancer-associated fibroblasts: understanding their heterogeneity. Cancers 12(11):3108","journal-title":"Cancers"},{"issue":"3","key":"5_CR73","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/CAD.0000000000001453","volume":"34","author":"X Lu","year":"2023","unstructured":"Lu X, Wang J, Dong B, Wang L, Liu Y (2023) Exosomal miR-93-5p from cancer-associated fibroblasts confers malignant phenotypes on bladder cancer cells by targeting PAFAH1B1. Anti-Cancer Drugs 34(3):439\u2013450","journal-title":"Anti-Cancer Drugs"},{"issue":"12","key":"5_CR74","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.ccell.2022.11.005","volume":"40","author":"Z Ma","year":"2022","unstructured":"Ma Z, Li X, Mao Y, Wei C, Huang Z, Li G, Yin J, Liang X, Liu Z (2022) Interferon-dependent SLC14A1+ cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer. Cancer Cell 40(12):1550\u20131565. e7","journal-title":"Cancer Cell"},{"issue":"7693","key":"5_CR75","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, Kadel EE, Koeppen H, Astarita JL, Cubas R, Jhunjhunwala S, Banchereau R, Yang Y, Guan Y, Chalouni C, Ziai J, \u015eenbabaog\u02c7lu Y, Santoro S, Sheinson D, Powles T (2018) TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature 554(7693):544\u2013548","journal-title":"Nature"},{"issue":"10","key":"5_CR76","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","volume":"21","author":"I Mart\u00ednez-Reyes","year":"2021","unstructured":"Mart\u00ednez-Reyes I, Chandel NS (2021) Cancer metabolism: looking forward. Nat Rev Cancer 21(10):669\u2013680","journal-title":"Nat Rev Cancer"},{"key":"5_CR77","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ctrv.2016.03.005","volume":"45","author":"F Massari","year":"2016","unstructured":"Massari F, Ciccarese C, Santoni M, Iacovelli R, Mazzucchelli R, Piva F, Scarpelli M, Berardi R, Tortora G, Lopez-Beltran A, Cheng L, Montironi R (2016) Metabolic phenotype of bladder cancer. Cancer Treat Rev 45:46\u201357","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"5_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-55013-0","volume":"10","author":"A Mezheyeuski","year":"2020","unstructured":"Mezheyeuski A, Segersten U, Leiss LW, Malmstr\u00f6m PU, Hatina J, \u00d6stman A, Strell C (2020) Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome. Sci Rep 10(1):1\u201312","journal-title":"Sci Rep"},{"issue":"15","key":"5_CR79","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.3390\/cancers14153810","volume":"14","author":"M Millet","year":"2022","unstructured":"Millet M, Bollmann E, Ringuette Goulet C, Bernard G, Chabaud S, Huot M\u00c9, Pouliot F, Bolduc S, Bordeleau F (2022) Cancer-associated fibroblasts in a 3D engineered tissue model induce tumor-like matrix stiffening and EMT transition. Cancers 14(15):3810","journal-title":"Cancers"},{"issue":"1","key":"5_CR80","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/cas.16385","volume":"116","author":"A Mitsuhashi","year":"2025","unstructured":"Mitsuhashi A, Nishioka Y (2025) Fibrocytes in tumor microenvironment: identification of their fraction and novel therapeutic strategy. Cancer Sci 116(1):21\u201328","journal-title":"Cancer Sci"},{"issue":"5","key":"5_CR81","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/dvg.22853","volume":"53","author":"H Miwa","year":"2015","unstructured":"Miwa H, Era T (2015) Generation and characterization of PDGFR\u03b1-GFPCreERt2 knock-in mouse line. Genesis 53(5):329\u2013336","journal-title":"Genesis"},{"issue":"10","key":"5_CR82","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.neo.2016.08.002","volume":"18","author":"M Miyake","year":"2016","unstructured":"Miyake M, Hori S, Morizawa Y, Tatsumi Y, Nakai Y, Anai S, Torimoto K, Aoki K, Tanaka N, Shimada K, Konishi N, Toritsuka M, Kishimoto T, Rosser CJ, Fujimoto K (2016) CXCL1-mediated interaction of cancer cells with tumor-associated macrophages and cancer-associated fibroblasts promotes tumor progression in human bladder cancer. Neoplasia 18(10):636\u2013646","journal-title":"Neoplasia"},{"issue":"1","key":"5_CR83","first-page":"1","volume":"11","author":"L Muhl","year":"2020","unstructured":"Muhl L, Genov\u00e9 G, Leptidis S, Liu J, He L, Mocci G, Sun Y, Gustafsson S, Buyandelger B, Chivukula IV, Segerstolpe \u00c5, Raschperger E, Hansson EM, Bj\u00f6rkegren JLM, Peng XR, Vanlandewijck M, Lendahl U, Betsholtz C (2020) Single-cell analysis uncovers fibroblast heterogeneity and criteria for fibroblast and mural cell identification and discrimination. Nat Commun 11(1):1\u201318","journal-title":"Nat Commun"},{"issue":"1","key":"5_CR84","doi-asserted-by":"publisher","first-page":"e248","DOI":"10.1038\/cddis.2011.123","volume":"3","author":"C Mu\u00f1oz-Pinedo","year":"2012","unstructured":"Mu\u00f1oz-Pinedo C, El Mjiyad N, Ricci JE (2012) Cancer metabolism: current perspectives and future directions. Cell Death Dis 3(1):e248\u2013e248","journal-title":"Cell Death Dis"},{"issue":"4","key":"5_CR85","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/ijc.32193","volume":"146","author":"M Nurmik","year":"2020","unstructured":"Nurmik M, Ullmann P, Rodriguez F, Haan S, Letellier E (2020) In search of definitions: cancer-associated fibroblasts and their markers. Int J Cancer 146(4):895\u2013905","journal-title":"Int J Cancer"},{"issue":"3","key":"5_CR86","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1084\/jem.20162024","volume":"214","author":"D \u00d6hlund","year":"2017","unstructured":"\u00d6hlund D, Handly-Santana A, Biffi G, Elyada E, Almeida AS, Ponz-Sarvise M, Corbo V, Oni TE, Hearn SA, Lee EJ, Chio IIC, Hwang CI, Tiriac H, Baker LA, Engle DD, Feig C, Kultti A, Egeblad M, Fearon DT et al (2017) Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J Exp Med 214(3):579\u2013596","journal-title":"J Exp Med"},{"issue":"3","key":"5_CR87","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","volume":"121","author":"A Orimo","year":"2005","unstructured":"Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion. Cell 121(3):335\u2013348","journal-title":"Cell"},{"issue":"8","key":"5_CR88","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1113\/JP273309","volume":"595","author":"SK Parks","year":"2017","unstructured":"Parks SK, Cormerais Y, Pouyss\u00e9gur J (2017) Hypoxia and cellular metabolism in tumour pathophysiology. J Physiol 595(8):2439\u20132450","journal-title":"J Physiol"},{"key":"5_CR89","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.semcancer.2014.02.006","volume":"25","author":"J Paulsson","year":"2014","unstructured":"Paulsson J, Micke P (2014) Prognostic relevance of cancer-associated fibroblasts in human cancer. Sem Cancer Biol 25:61\u201368","journal-title":"Sem Cancer Biol"},{"key":"5_CR90","doi-asserted-by":"crossref","unstructured":"Pavlides S, Whitaker-Menezes D, Castello-Cros R, Flomenberg N, Witkiewicz AK, Frank PG, Casimiro MC, Wang C, Fortina P, Addya S, Pestell RG, Martinez-Outschoorn UE, Sotgia F, Lisanti MP (2009) The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle 8(23):3984\u20134001","DOI":"10.4161\/cc.8.23.10238"},{"key":"5_CR91","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/978-3-030-34025-4_3","volume":"1219","author":"A Pereira-Nunes","year":"2020","unstructured":"Pereira-Nunes A, Afonso J, Granja S, Baltazar F (2020) Lactate and lactate transporters as key players in the maintenance of the Warburg effect. Adv Exp Med Biol 1219:51\u201374","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"5_CR92","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.yexcr.2011.11.014","volume":"318","author":"YI Rattigan","year":"2012","unstructured":"Rattigan YI, Patel BB, Ackerstaff E, Sukenick G, Koutcher JA, Glod JW, Banerjee D (2012) Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironment. Exp Cell Res 318(4):326\u2013335","journal-title":"Exp Cell Res"},{"key":"5_CR93","doi-asserted-by":"publisher","first-page":"114504","DOI":"10.1016\/j.addr.2022.114504","volume":"189","author":"R Rimal","year":"2022","unstructured":"Rimal R, Desai P, Daware R, Hosseinnejad A, Prakash J, Lammers T, Singh S (2022) Cancer-associated fibroblasts: origin, function, imaging, and therapeutic targeting. Adv Drug Deliv Rev 189:114504","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"5_CR94","first-page":"15","volume":"8","author":"K Saginala","year":"2020","unstructured":"Saginala K, Barsouk A, Aluru JS, Rawla P, Padala SA, Barsouk A (2020) Epidemiology of bladder cancer. Med Sci 8(1):15","journal-title":"Med Sci"},{"issue":"3","key":"5_CR95","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, Fearon D, Greten FR, Hingorani SR, Hunter T, Hynes RO, Jain RK, Janowitz T, Jorgensen C, Kimmelman AC, Kolonin MG, Maki RG, Powers RS, Pur\u00e9 E  et al (2020) A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer 20(3):174\u2013186","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"5_CR96","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/path.4281","volume":"231","author":"P Sandoval","year":"2013","unstructured":"Sandoval P, Jim\u00e9nez-Heffernan JA, Rynne-Vidal \u00c1, P\u00e9rez-Lozano ML, Gilsanz \u00c1, Ruiz-Carpio V, Reyes R, Garc\u00eda-Bordas J, Stamatakis K, Dotor J, Majano PL, Fresno M, Caba\u00f1as C, L\u00f5pez-Cabrera M (2013) Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis. J Pathol 231(4):517\u2013531","journal-title":"J Pathol"},{"issue":"6","key":"5_CR97","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/S00418-012-0998-0\/FIGURES\/5","volume":"138","author":"J Schulte","year":"2012","unstructured":"Schulte J, Weidig M, Balzer P, Richter P, Franz M, Junker K, Gajda M, Friedrich K, Wunderlich H, \u00d6stman A, Petersen I, Berndt A (2012) Expression of the E-cadherin repressors snail, slug and Ze\u03b21 in urothelial carcinoma of the urinary bladder: relation to stromal fibroblast activation and invasive behaviour of carcinoma cells. Histochem Cell Biol 138(6):847\u2013860. https:\/\/doi.org\/10.1007\/S00418-012-0998-0\/FIGURES\/5","journal-title":"Histochem Cell Biol"},{"issue":"1","key":"5_CR98","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s13402-020-00500-0","volume":"44","author":"G Shan","year":"2021","unstructured":"Shan G, Zhou X, Gu J, Zhou D, Cheng W, Wu H, Wang Y, Tang T, Wang X (2021) Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt\/\u03b2-catenin pathway and upregulating PTEN. Cell Oncol 44(1):45\u201359","journal-title":"Cell Oncol"},{"issue":"19","key":"5_CR99","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1080\/15384101.2015.1053666","volume":"14","author":"H Shi","year":"2015","unstructured":"Shi H, Jiang H, Wang L, Cao Y, Liu P, Xu X, Wang Y, Sun L, Niu H (2015) Overexpression of monocarboxylate anion transporter 1 and 4 in T24-induced cancer-associated fibroblasts regulates the progression of bladder cancer cells in a 3D microfluidic device. Cell Cycle 14(19):3058\u20133065","journal-title":"Cell Cycle"},{"issue":"1","key":"5_CR100","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrd.2016.193","volume":"16","author":"Y Shi","year":"2016","unstructured":"Shi Y, Du L, Lin L, Wang Y (2016) Tumour-associated mesenchymal stem\/stromal cells: emerging therapeutic targets. Nat Rev Drug Discov 16(1):35\u201352","journal-title":"Nat Rev Drug Discovery"},{"issue":"4","key":"5_CR101","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.ccell.2014.09.001","volume":"26","author":"K Shin","year":"2014","unstructured":"Shin K, Lim A, Zhao C, Sahoo D, Pan Y, Spiekerkoetter E, Liao JC, Beachy PA (2014) Hedgehog signaling restrains bladder cancer progression by eliciting stromal production of urothelial differentiation factors. Cancer Cell 26(4):521\u2013533","journal-title":"Cancer Cell"},{"issue":"6","key":"5_CR102","doi-asserted-by":"publisher","first-page":"5141","DOI":"10.3390\/ijms24065141","volume":"24","author":"A Silva","year":"2023","unstructured":"Silva A, Cerqueira MC, Rosa B, Sobral C, Pinto-Ribeiro F, Costa MF, Baltazar F, Afonso J (2023a) Prognostic value of monocarboxylate transporter 1 overexpression in cancer: a systematic review. Int J Mol Sci 24(6):5141","journal-title":"Int J Mol Sci"},{"issue":"12","key":"5_CR103","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.3390\/pharmaceutics15122688","volume":"15","author":"A Silva","year":"2023","unstructured":"Silva A, F\u00e9lix A, Cerqueira M, Gon\u00e7alves CS, Sampaio-Marques B, Longatto-Filho A, Baltazar F, Afonso J (2023b) Effects of lactate transport inhibition by AZD3965 in muscle-invasive urothelial bladder cancer. Pharmaceutics 15(12):2688","journal-title":"Pharmaceutics"},{"issue":"6","key":"5_CR104","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.bbabio.2010.09.003","volume":"1807","author":"G Solaini","year":"2011","unstructured":"Solaini G, Sgarbi G, Baracca A (2011) Oxidative phosphorylation in cancer cells. Biochim Biophys Acta Bioenerg 1807(6):534\u2013542","journal-title":"Biochim Biophys Acta Bioenerg"},{"issue":"4","key":"5_CR105","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.cell.2018.01.009","volume":"172","author":"S Su","year":"2018","unstructured":"Su S, Chen J, Yao H, Liu J, Yu S, Lao L, Wang M, Luo M, Xing Y, Chen F, Huang D, Zhao J, Yang L, Liao D, Su F, Li M, Liu Q, Song E (2018) CD10+GPR77+ cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness. Cell 172(4):841\u2013856. e16","journal-title":"Cell"},{"issue":"3","key":"5_CR106","doi-asserted-by":"publisher","first-page":"e286","DOI":"10.5301\/jbm.5000189","volume":"31","author":"CM Sun","year":"2016","unstructured":"Sun CM, Xiong DB, Yan Y, Geng J, Liu M, Yao XD (2016) Genetic alteration in phosphofructokinase family promotes growth of muscle-invasive bladder cancer. Int J Biol Markers 31(3):e286\u2013e293","journal-title":"Int J Biol Markers"},{"issue":"9","key":"5_CR107","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/nm.2890","volume":"18","author":"Y Sun","year":"2012","unstructured":"Sun Y, Campisi J, Higano C, Beer TM, Porter P, Coleman I, True L, Nelson PS (2012) Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nat Med 18(9):1359\u20131368","journal-title":"Nat Med"},{"issue":"1","key":"5_CR108","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3390\/cancers5010149","volume":"5","author":"S Togo","year":"2013","unstructured":"Togo S, Polanska UM, Horimoto Y, Orimo A (2013) Carcinoma-associated fibroblasts are a promising therapeutic target. Cancers 5(1):149\u2013169","journal-title":"Cancers"},{"issue":"6","key":"5_CR109","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/emmm.201000073","volume":"2","author":"A Toullec","year":"2010","unstructured":"Toullec A, Gerald D, Despouy G, Bourachot B, Cardon M, Lefort S, Richardson M, Rigaill G, Parrini MC, Lucchesi C, Bellanger D, Stern MH, Dubois T, Sastre-Garau X, Delattre O, Vincent-Salomon A, Mechta-Grigoriou F (2010) Oxidative stress promotes myofibroblast differentiation and tumour spreading. EMBO Mol Med 2(6):211\u2013230","journal-title":"EMBO Mol Med"},{"issue":"2","key":"5_CR110","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10456-019-09688-8","volume":"23","author":"D Unterleuthner","year":"2020","unstructured":"Unterleuthner D, Neuhold P, Schwarz K, Janker L, Neuditschko B, Nivarthi H, Crncec I, Kramer N, Unger C, Hengstschl\u00e4ger M, Eferl R, Moriggl R, Sommergruber W, Gerner C, Dolznig H (2020) Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer. Angiogenesis 23(2):159\u2013177","journal-title":"Angiogenesis"},{"key":"5_CR111","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.omtn.2019.11.024","volume":"19","author":"H Wang","year":"2020","unstructured":"Wang H, Wei H, Wang J, Li L, Chen A, Li Z (2020) MicroRNA-181d-5p-containing exosomes derived from CAFs promote EMT by regulating CDX2\/HOXA5 in breast cancer. Mol Ther Nucleic Acids 19:654\u2013667","journal-title":"Mol Ther Nucleic Acids"},{"issue":"44","key":"5_CR112","doi-asserted-by":"publisher","first-page":"76116","DOI":"10.18632\/oncotarget.18814","volume":"8","author":"L Wang","year":"2017","unstructured":"Wang L, Cao L, Wang H, Liu B, Zhang Q, Meng Z, Wu X, Zhou Q, Xu K (2017) Cancer-associated fibroblasts enhance metastatic potential of lung cancer cells through IL-6\/STAT3 signaling pathway. Oncotarget 8(44):76116","journal-title":"Oncotarget"},{"issue":"1","key":"5_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13577-021-00622-z","volume":"35","author":"X Wang","year":"2021","unstructured":"Wang X, Liu H, Ni Y, Shen P, Han X (2021) Lactate shuttle: from substance exchange to regulatory mechanism. Hum Cell 35(1):1\u201314","journal-title":"Hum Cell"},{"key":"5_CR114","doi-asserted-by":"publisher","first-page":"613534","DOI":"10.3389\/FCELL.2021.613534\/BIBTEX","volume":"9","author":"Z Wang","year":"2021","unstructured":"Wang Z, Yang Q, Tan Y, Tang Y, Ye J, Yuan B, Yu W (2021) Cancer-associated fibroblasts suppress cancer development: the other side of the coin. Front Cell Dev Biol 9:613534. https:\/\/doi.org\/10.3389\/FCELL.2021.613534\/BIBTEX","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"5_CR115","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1053\/j.seminoncol.2017.10.004","volume":"44","author":"L Wilde","year":"2017","unstructured":"Wilde L, Roche M, Domingo-Vidal M, Tanson K, Philp N, Curry J, Martinez-Outschoorn U (2017) Metabolic coupling and the reverse Warburg effect in cancer: implications for novel biomarker and anticancer agent development. Semin Oncol 44(3):198\u2013203","journal-title":"Semin Oncol"},{"issue":"5","key":"5_CR116","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.3390\/cancers12051181","volume":"12","author":"M Wo\u0142\u0105cewicz","year":"2020","unstructured":"Wo\u0142\u0105cewicz M, Hrynkiewicz R, Grywalska E, Suchojad T, Leksowski T, Roli\u0144ski J, Nied\u017awiedzka-Rystwej P (2020) Immunotherapy in bladder cancer: current methods and future perspectives. Cancers 12(5):1181","journal-title":"Cancers"},{"issue":"13","key":"5_CR117","doi-asserted-by":"publisher","first-page":"20741","DOI":"10.18632\/oncotarget.15119","volume":"8","author":"X Wu","year":"2017","unstructured":"Wu X, Tao P, Zhou Q, Li J, Yu Z, Wang X, Li J, Li C, Yan M, Zhu Z, Liu B, Su L (2017) IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2\/STAT3 signaling pathway. Oncotarget 8(13):20741","journal-title":"Oncotarget"},{"issue":"1","key":"5_CR118","doi-asserted-by":"publisher","first-page":"166","DOI":"10.2741\/3613","volume":"15","author":"F Xing","year":"2010","unstructured":"Xing F, Saidou J, Watabe K (2010) Cancer associated fibroblasts (CAFs) in tumor microenvironment. Front Biosci J Virtual Library 15(1):166","journal-title":"Front Biosci J Virtual Library"},{"issue":"8","key":"5_CR119","first-page":"12327","volume":"8","author":"XD Xu","year":"2015","unstructured":"Xu XD, Shao SX, Cao YW, Yang XC, Shi HQ, Wang YL, Xue SY, Wang XS, Niu HT (2015a) The study of energy metabolism in bladder cancer cells in co-culture conditions using a microfluidic chip. Int J Clin Exp Med 8(8):12327","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"5_CR120","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000375435","volume":"38","author":"XD Xu","year":"2015","unstructured":"Xu XD, Shao SX, Jiang HP, Cao YW, Wang YH, Yang XC, Wang YL, Wang XS, Niu HT (2015b) Warburg effect or reverse Warburg effect? A review of cancer metabolism. Oncol Res Treat 38(3):117\u2013122","journal-title":"Oncol Res Treat"},{"issue":"1","key":"5_CR121","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4149\/neo_2020_200202N101","volume":"68","author":"F Yang","year":"2021","unstructured":"Yang F, Guo Z, He C, Qing L, Wang H, Wu J, Lu X (2021) Cancer-associated fibroblasts promote cell proliferation and invasion via paracrine Wnt\/IL1\u03b2 signaling pathway in human bladder cancer. Neoplasma 68(1):79\u201386","journal-title":"Neoplasma"},{"key":"5_CR122","doi-asserted-by":"publisher","first-page":"109675","DOI":"10.1016\/j.cellsig.2020.109675","volume":"73","author":"F Yang","year":"2020","unstructured":"Yang F, Yan Y, Yang Y, Hong X, Wang M, Yang Z, Liu B, Ye L (2020) MiR-210 in exosomes derived from CAFs promotes non-small cell lung cancer migration and invasion through PTEN\/PI3K\/AKT pathway. Cell Signalling 73:109675","journal-title":"Cell Signalling"},{"issue":"3","key":"5_CR123","first-page":"1146","volume":"5","author":"C-R Yeh","year":"2015","unstructured":"Yeh C-R, Hsu I, Song W, Chang H, Miyamoto H, Xiao G-Q, Li L, Yeh S (2015) Fibroblast ER\u03b1 promotes bladder cancer invasion via increasing the CCL1 and IL-6 signals in the tumor microenvironment. Am J Cancer Res 5(3):1146","journal-title":"Am J Cancer Res"},{"issue":"70","key":"5_CR124","doi-asserted-by":"publisher","first-page":"114769","DOI":"10.18632\/oncotarget.23082","volume":"8","author":"J You","year":"2017","unstructured":"You J, Li M, Tan Y, Cao L, Gu Q, Yang H, Hu C (2017) Snail1-expressing cancer-associated fibroblasts induce lung cancer cell epithelial-mesenchymal transition through miR-33b. Oncotarget 8(70):114769","journal-title":"Oncotarget"},{"issue":"21","key":"5_CR125","doi-asserted-by":"publisher","first-page":"10123","DOI":"10.1158\/0008-5472.CAN-07-3127","volume":"67","author":"EM Zeisberg","year":"2007","unstructured":"Zeisberg EM, Potenta S, Xie L, Zeisberg M, Kalluri R (2007) Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res 67(21):10123\u201310128","journal-title":"Cancer Res"},{"issue":"7","key":"5_CR126","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1158\/0008-5472.CAN-17-1366","volume":"78","author":"D Zhang","year":"2018","unstructured":"Zhang D, Li L, Jiang H, Li Q, Wang-Gillam A, Yu J, Head R, Liu J, Ruzinova MB, Lim KH (2018) Tumor\u2013Stroma IL1b-IRAK4 feedforward circuitry drives tumor fibrosis, chemoresistance, and poor prognosis in pancreatic cancer. Cancer Res 78(7):1700\u20131712","journal-title":"Cancer Res"},{"key":"5_CR127","doi-asserted-by":"publisher","first-page":"1121586","DOI":"10.3389\/fphar.2023.1121586","volume":"14","author":"J Zhang","year":"2023","unstructured":"Zhang J, Lu S, Lu T, Han D, Zhang K, Gan L, Wu X, Li Y, Zhao X, Li Z, Shen Y, Hu S, Yang F, Wen W, Qin W (2023) Single-cell analysis reveals the COL11A1+ fibroblasts are cancer-specific fibroblasts that promote tumor progression. Front Pharmacol 14:1121586","journal-title":"Front Pharmacol"},{"issue":"10","key":"5_CR128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-022-05351-1","volume":"13","author":"T Zhang","year":"2022","unstructured":"Zhang T, Ren Y, Yang P, Wang J, Zhou H (2022) Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Cell Death Dis 13(10):1\u201311","journal-title":"Cell Death Dis"},{"issue":"2","key":"5_CR129","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s13577-022-00673-w","volume":"35","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Liang Z, Li D, Wang L, Chen Y, Liang Y, Jiao W, Niu H (2022) Development of a CAFs-related gene signature to predict survival and drug response in bladder cancer. Hum Cell 35(2):649\u2013664","journal-title":"Hum Cell"},{"key":"5_CR130","doi-asserted-by":"crossref","unstructured":"Zhou H, Li R, Liu J, Long J, Chen T (2024) Characterization and verification of CAF-relevant prognostic gene signature to aid therapy in bladder cancer. Heliyon 10(3)","DOI":"10.1016\/j.heliyon.2023.e23873"},{"issue":"1","key":"5_CR131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep11924","volume":"5","author":"J Zhuang","year":"2015","unstructured":"Zhuang J, Lu Q, Shen B, Huang X, Shen L, Zheng X, Huang R, Yan J, Guo H (2015) TGF\u03b21 secreted by cancer-associated fibroblasts induces epithelial-mesenchymal transition of bladder cancer cells through lncRNA-ZEB2NAT. Sci Rep 5(1):1\u201313","journal-title":"Sci Rep"}],"container-title":["Advances in Experimental Medicine and Biology","Cancer Metabolic Remodeling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-12166-0_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T12:02:14Z","timestamp":1783771334000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-032-12166-0_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9783032121653","9783032121660"],"references-count":131,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-12166-0_5","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"12 July 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}